Produktname:5-bromo-N4-[5-(dimethylphosphinyl)-6-quinoxalinyl]-N2-[2-methoxy-5-methyl-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-2,4-pyrimidinediamine
IUPAC Name:5-bromo-N4-[5-(dimethylphosphoryl)quinoxalin-6-yl]-N2-{2-methoxy-5-methyl-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}pyrimidine-2,4-diamine
- CAS:2267329-76-8
- Molekulare Formel:C32H41BrN9O2P
- Reinheit:95%+
- Katalognummer:CM456029
- Molekulargewicht:694.62
Nur für den Einsatz in Forschung und Entwicklung..
Produkt-Details
- CAS-Nr.:2267329-76-8
- Molekulare Formel:C32H41BrN9O2P
- Schmelzpunkt:-
- SMILES-Code:COC1=C(NC2=NC(Nc3ccc4nccnc4c3P(C)(C)=O)=C(Br)C=N2)C=C(C)C(=C1)N1CCC(CC1)N1CCN(C)CC1
- Dichte:
- Katalognummer:CM456029
- Molekulargewicht:694.62
- Siedepunkt:
- Mdl-Nr.:
- Lagerung:
Category Infos
- Quinoxalines
- Quinoxalines, also known as benzopyrazines, are heterocyclic compounds containing a ring complex consisting of a benzene ring and a pyrazine ring. It has isomerism with other naphthalene compounds such as quinazoline, phthalazine, cinnamine, etc. Fusion N-heterocyclic compounds are widely used as valuable entities for the expansion of important pharmacological agents and are considered to be an advantageous scaffold material. Among the numerous fused N-heterocyclic compounds, cinnoline, quinoxaline and quinazoline are important pharmacological agents. In medicinal chemistry, these N-heterocyclic compounds have a wide range of biological properties and can be used as synthetic intermediates, potential drug candidates and chemical probes.